Human Papillomavirus Type 16 E5-mediated Upregulation of Met in Human Keratinocytes

Overview

Journal Virology

Specialty Microbiology

Date 2018 Apr 3

PMID 29609071

Citations 21

Authors

Matthew L Scott

David T Coleman

Kinsey C Kelly

Jennifer L Carroll

Brittany Woodby

William K Songock

James A Cardelli

Jason M Bodily

Affiliations

Soon will be listed here.

Abstract

Human papillomaviruses (HPVs) cause benign lesions that can lead to malignancy. How cellular changes induced by viral oncogenes contribute to the progeny virion production is not always clear. Stromally-derived growth factors and their receptors are critical for development of malignancy, but their impact on the pre-malignant HPV life cycle is unknown. We show that HPV16 increases levels of Met, a growth factor receptor critical for tumor cell invasion, motility, and cancer metastasis. The viral oncogene E5 is primarily responsible for Met upregulation, with E6 playing a minor role. Met induction by E5 requires the epidermal growth factor receptor, which is also increased by E5 at the mRNA level. E5-induced Met contributes motility of HPV-containing cells. Finally, Met signaling is necessary for viral gene expression, particularly in the differentiation-dependent phase of the viral life cycle. These studies show a new role for E5 in epithelial-stromal interactions, with implications for cancer development.

Citing Articles

Virus-mediated immunosuppression in head and neck cancer.

Miyauchi S, Roy S, Boutros N, Sharabi A Oncogene. 2025; .

PMID: 40074885 DOI: 10.1038/s41388-025-03295-2.

Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis.

Otalora-Otalora B, Payan-Gomez C, Lopez-Rivera J, Pedroza-Aconcha N, Aristizabal-Guzman C, Isaza-Ruget M Front Cell Infect Microbiol. 2024; 14:1425388.

PMID: 39228892 PMC: 11368877. DOI: 10.3389/fcimb.2024.1425388.

HPV-driven oncogenesis-much more than the E6 and E7 oncoproteins.

Janiszewska J, Kostrzewska-Poczekaj M, Wierzbicka M, Brenner J, Giefing M J Appl Genet. 2024; 66(1):63-71.

PMID: 38907809 PMC: 11761861. DOI: 10.1007/s13353-024-00883-y.

HPV16 E7 modulates the cell surface expression of MET and CD109 via the AP2 complex.

Trejo-Cerro O, Basukala O, Myers M, Banks L Tumour Virus Res. 2024; 17:200279.

PMID: 38485055 PMC: 10958106. DOI: 10.1016/j.tvr.2024.200279.

Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.

Heydarnia E, Dorostgou Z, Hedayati N, Mousavi V, Yahyazadeh S, Alimohammadi M Cell Commun Signal. 2024; 22(1):107.

PMID: 38341592 PMC: 10859032. DOI: 10.1186/s12964-024-01494-0.

References

Wilson R, Laimins L . Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol Med. 2005; 119:157-69. DOI: 10.1385/1-59259-982-6:157. View

Baykal C, Ayhan A, Al A, Yuce K, Ayhan A . Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynecol Oncol. 2003; 88(2):123-9. DOI: 10.1016/s0090-8258(02)00073-2. View

Sahab Z, Sudarshan S, Liu X, Zhang Y, Kirilyuk A, Kamonjoh C . Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry. J Virol. 2012; 86(17):9465-73. PMC: 3416135. DOI: 10.1128/JVI.01032-12. View

Polanska U, Orimo A . Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol. 2013; 228(8):1651-7. DOI: 10.1002/jcp.24347. View

Latorre I, Roh M, Frese K, Weiss R, Margolis B, Javier R . Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci. 2005; 118(Pt 18):4283-93. PMC: 3471650. DOI: 10.1242/jcs.02560. View

Klingelhutz A, Roman A . Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology. 2012; 424(2):77-98. PMC: 3703738. DOI: 10.1016/j.virol.2011.12.018. View

Steele B, Meyers C, Ozbun M . Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal Biochem. 2002; 307(2):341-7. DOI: 10.1016/s0003-2697(02)00045-3. View

DCosta Z, Jolly C, Androphy E, Mercer A, Matthews C, Hibma M . Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PLoS One. 2012; 7(11):e48954. PMC: 3506579. DOI: 10.1371/journal.pone.0048954. View

den Boon J, Pyeon D, Wang S, Horswill M, Schiffman M, Sherman M . Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015; 112(25):E3255-64. PMC: 4485108. DOI: 10.1073/pnas.1509322112. View

10.

Hwang C, Matoso A, Corney D, Flesken-Nikitin A, Korner S, Wang W . Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A. 2011; 108(34):14240-5. PMC: 3161601. DOI: 10.1073/pnas.1017536108. View

11.

zur Hausen H . Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta. 1996; 1288(2):F55-78. DOI: 10.1016/0304-419x(96)00020-0. View

12.

Drake L, Macleod K . Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again?. J Pathol. 2013; 232(3):283-8. PMC: 6664431. DOI: 10.1002/path.4298. View

13.

Pim D, Thomas M, Banks L . Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene. 2002; 21(53):8140-8. DOI: 10.1038/sj.onc.1206026. View

14.

Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo M . Papillomavirus E5: the smallest oncoprotein with many functions. Mol Cancer. 2011; 10:140. PMC: 3248866. DOI: 10.1186/1476-4598-10-140. View

15.

Doorbar J, Quint W, Banks L, Bravo I, Stoler M, Broker T . The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30 Suppl 5:F55-70. DOI: 10.1016/j.vaccine.2012.06.083. View

16.

Lopes-Bastos B, Jiang W, Cai J . Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis. Anticancer Res. 2016; 36(3):1119-26. View

17.

Jung Y, Kato I, Kim H . A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2013; 435(3):339-44. DOI: 10.1016/j.bbrc.2013.04.060. View

18.

Hsieh C, Tsao Y, Wang C, Han C, Chang J, Lee J . Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens. Arch Virol. 2001; 145(11):2273-84. DOI: 10.1007/s007050070020. View

19.

Walker F, Kermorgant S, Darai E, Madelenat P, Cremieux A, Henin D . Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus. Clin Cancer Res. 2003; 9(1):273-84. View

20.

Bodily J, Hennigan C, Wrobel G, Rodriguez C . Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle. Virology. 2013; 443(1):11-9. PMC: 5789804. DOI: 10.1016/j.virol.2013.04.033. View